CLINICAL TRIALS PROFILE FOR AIMOVIG
✉ Email this page to a colleague
All Clinical Trials for AIMOVIG
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03773562 ↗ | Imaging the Migraine Brain Pre- and Post-Erenumab | Recruiting | Mayo Clinic | Phase 4 | 2019-03-25 | The aims of this study are to: 1. Identify changes in brain function and structure that correlate with response to erenumab. 2. Develop models using imaging data +/- clinical data to predict which patients will respond to erenumab. Pre-treatment and early post-treatment imaging data will be used separately for predictive modeling. |
NCT03912337 ↗ | Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine | Terminated | Novartis | Phase 4 | 2019-12-04 | To evaluate the effect of erenumab compared to placebo on disability in employed subjects with episodic migraine (EM) who have previously failed 1 or more migraine preventive treatments. |
NCT03912337 ↗ | Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine | Terminated | Amgen | Phase 4 | 2019-12-04 | To evaluate the effect of erenumab compared to placebo on disability in employed subjects with episodic migraine (EM) who have previously failed 1 or more migraine preventive treatments. |
NCT03971071 ↗ | A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache | Recruiting | Amgen | Phase 4 | 2019-10-07 | Study 20170703 is a phase 4, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of erenumab against placebo in subjects with chronic migraine (CM) who have a history of at least 1 preventive treatment failure and are diagnosed with medication overuse headache (MOH). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AIMOVIG
Condition Name
Clinical Trial Locations for AIMOVIG
Trials by Country
Clinical Trial Progress for AIMOVIG
Clinical Trial Phase
Clinical Trial Sponsors for AIMOVIG
Sponsor Name